Actively Recruiting
Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
Led by Assiut University · Updated on 2024-09-26
48
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the albumin bilirubin index to predict the risk of recurrent bleeding within three months after endoscopic treatment in patients with cirrhosis and esophagogastric variceal bleeding (EGVB). The study aims to clarify how well this index can forecast bleeding outcomes, which may help guide future care for affected patients. The research is observational and sponsored by Assiut University. Participants will be observed following their endoscopic treatment without receiving additional experimental interventions. The study focuses on monitoring patients over time to evaluate the relationship between their albumin bilirubin index levels and bleeding recurrence. No specific treatments or procedures beyond standard care are assigned by the study. During the study, participants' health and bleeding status will be regularly assessed to track the prevalence of variceal bleeding in those with a high albumin bilirubin index over six months. Data collection will include clinical evaluations and laboratory tests as part of routine care. The study duration and follow-up are structured to gather meaningful information on this predictive marker's value.
CONDITIONS
Brief Title
Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years old
You will not qualify if you...
- Hepatocellular carcinoma (HCC)
- Hematological disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 3 months
Participants are observed to clarify the predictive value of albumin bilirubin index for recurrent bleeding within 3 months after endoscopic treatment.
Trial Site Locations
Total: 1 location
1
Assiut university hospital
Asyut, Egypt, Assiut
Actively Recruiting
Research Team
H
Heba Sayed Zaki
A
Ahmed M.Ashmawy
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here